BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luis-Martínez R, Di Marco R, Weis L, Cianci V, Pistonesi F, Baba A, Carecchio M, Biundo R, Tedesco C, Masiero S, Antonini A. Impact of social and mobility restrictions in Parkinson's disease during COVID-19 lockdown. BMC Neurol 2021;21:332. [PMID: 34461838 DOI: 10.1186/s12883-021-02364-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Erica Tardelli, Acácio Moreira-Neto, Erika Okamoto, Fernanda Rogatto, Mario Vergari-Filho, Egberto Reis Barbosa, Carla Silva-Batista. Telerehabilitation during social distancing for people with Parkinson’s disease: a retrospective study. Acta Neurol Belg 2022. [PMID: 36527572 DOI: 10.1007/s13760-022-02160-3] [Reference Citation Analysis]
2 Dolan C, Mcdermott A. The impact of Covid-19 restrictions in Ireland on symptom severity in mild to moderate Parkinson’s disease. British Journal of Occupational Therapy. [DOI: 10.1177/03080226221120477] [Reference Citation Analysis]
3 Kamimoto T, Kawakami M, Morita T, Miyazaki Y, Hijikata N, Akimoto T, Tsujikawa M, Honaga K, Suzuki K, Kondo K, Tsuji T. Effects of the COVID-19 Pandemic on Physical Function of Community-Dwelling People with Disabilities in Japan. Int J Environ Res Public Health 2022;19. [PMID: 36231898 DOI: 10.3390/ijerph191912599] [Reference Citation Analysis]
4 Mai AS, Yong JH, Tan BJ, Xiao B, Tan EK. Impact of COVID-19 pandemic on patients with Parkinson's disease: A meta-analysis of 13,878 patients. Ann Clin Transl Neurol 2022. [PMID: 36065787 DOI: 10.1002/acn3.51616] [Reference Citation Analysis]
5 Shalash A, Helmy A, Salama M, Gaber A, El-belkimy M, Hamid E. A 6-month longitudinal study on worsening of Parkinson’s disease during the COVID-19 pandemic. npj Parkinsons Dis 2022;8:111. [DOI: 10.1038/s41531-022-00376-x] [Reference Citation Analysis]
6 Štefancová V, Kalašová A, Čulík K, Mazanec J, Vojtek M, Mašek J. Research on the Impact of COVID-19 on Micromobility Using Statistical Methods. Applied Sciences 2022;12:8128. [DOI: 10.3390/app12168128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Anghelescu A. Telerehabilitation: A Practical Remote Alternative for Coaching and Monitoring Physical Kinetic Therapy in Patients with Mild and Moderate Disabling Parkinson’s Disease during the COVID-19 Pandemic. Parkinson's Disease 2022;2022:1-9. [DOI: 10.1155/2022/4370712] [Reference Citation Analysis]
8 Mameli F, Zirone E, Capetti B, Mellace D, Ferrucci R, Franco G, Di Fonzo A, Barbieri S, Ruggiero F. Changes in non-motor symptoms in patients with Parkinson's disease following COVID-19 pandemic restrictions: A systematic review. Front Psychol 2022;13:939520. [DOI: 10.3389/fpsyg.2022.939520] [Reference Citation Analysis]
9 Helvaci Yilmaz N, Bolluk Kilic B, Zirh TA, Aslan AS, Hanoglu L. Parkinson’s Disease and the COVID-19 Pandemic: Do Quarantine Affect the Motor and Non-Motor Symptoms of Patients with and without Deep Brain Stimulation? Haseki 2022;60:204-210. [DOI: 10.4274/haseki.galenos.2022.8225] [Reference Citation Analysis]
10 Wolff AW, Haller B, Demleitner AF, Westenberg E, Lingor P. Impact of the COVID-19 Pandemic on Patients with Parkinson’s Disease from the Perspective of Treating Physicians—A Nationwide Cross-Sectional Study. Brain Sciences 2022;12:353. [DOI: 10.3390/brainsci12030353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Di Marco R, Pistonesi F, Cianci V, Biundo R, Weis L, Tognolo L, Baba A, Rubega M, Gentile G, Tedesco C, Carecchio M, Antonini A, Masiero S. Effect of Intensive Rehabilitation Program in Thermal Water on a Group of People with Parkinson’s Disease: A Retrospective Longitudinal Study. Healthcare 2022;10:368. [DOI: 10.3390/healthcare10020368] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Chandra A, Johri A. A Peek into Pandora’s Box: COVID-19 and Neurodegeneration. Brain Sciences 2022;12:190. [DOI: 10.3390/brainsci12020190] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
13 Rukavina K, Mcconvey V, Ray Chaudhuri K, Miyasaki J. Parkinson's disease and Covid-19: Is there an impact of ethnicity and the need for palliative care. International Review of Neurobiology 2022. [DOI: 10.1016/bs.irn.2022.03.004] [Reference Citation Analysis]
14 Leta V, Boura I, van Wamelen DJ, Rodriguez-Violante M, Antonini A, Chaudhuri KR. Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism. Int Rev Neurobiol 2022;165:63-89. [PMID: 36208907 DOI: 10.1016/bs.irn.2022.04.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Rota S, Boura I, Wan Y, Lazcano-ocampo C, Rodriguez-violante M, Antonini A, Chaudhuri KR. Spotlight on non-motor symptoms and Covid-19. International Review of Neurobiology 2022. [DOI: 10.1016/bs.irn.2022.04.001] [Reference Citation Analysis]
16 Krzysztoń K, Mielańczuk-lubecka B, Stolarski J, Poznańska A, Kępczyńska K, Zdrowowicz A, Domitrz I, Kochanowski J. Secondary Impact of COVID-19 Pandemic on People with Parkinson’s Disease—Results of a Polish Online Survey. Brain Sciences 2022;12:26. [DOI: 10.3390/brainsci12010026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
17 Knapik A, Szefler-Derela J, Wasiuk-Zowada D, Siuda J, Krzystanek E, Brzęk A. Isolation Related to the COVID-19 Pandemic in People Suffering from Parkinson's Disease and Activity, Self-Assessment of Physical Fitness and the Level of Affective Disorders. Healthcare (Basel) 2021;9:1562. [PMID: 34828608 DOI: 10.3390/healthcare9111562] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]